Literature DB >> 17762705

Homocysteine is toxic for dopaminergic neurons in primary mesencephalic culture.

Keiko Imamura1, Takao Takeshima, Kazuhiro Nakaso, Kenji Nakashima.   

Abstract

Hyperhomocysteinemia associated with L-3,4-dihydroxyphenylalanine (L-dopa) treatment has been observed in patients with Parkinson's disease. We investigated the toxicity of homocysteine (Hcy) on E14-rat-primary mesencephalic culture. Exposure to 0-5 mM Hcy decreased number of tyrosine hydroxylase (TH)-positive dopaminergic neurons and microtubule associated protein 2 (MAP2)-positive neurons in a dose-dependent manner. TH-positive neurons had vulnerability to the insult of Hcy compared with the other MAP2-positive neurons. In dopaminergic neurons, 5 microM reserpine enhanced the Hcy toxicity, whereas 50 microM alpha-methyltyrosine attenuated the toxic effect, showing that the intracellular dopamine increased the cytotoxicity of Hcy. Hcy enhanced the toxicity of 1-methyl-4-phenylpyridinium (MPP+) for dopaminergic neurons. It was suggested that the Hcy toxicity was associated with the oxidative stress. Hcy is toxic for dopaminergic neurons, and hyperhomocysteinemia may modify the clinical course of Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17762705     DOI: 10.1097/WNR.0b013e3282aaa0b4

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  8 in total

1.  Elevation of total homocysteine levels in patients with Parkinson's disease treated with duodenal levodopa/carbidopa gel.

Authors:  Thomas Müller; Constanze Jugel; Reinhard Ehret; Georg Ebersbach; Gunar Bengel; Siegfried Muhlack; Fabian Klostermann
Journal:  J Neural Transm (Vienna)       Date:  2011-02-27       Impact factor: 3.575

2.  Association of MTHFR C677T with total homocysteine plasma levels and susceptibility to Parkinson's disease: a meta-analysis.

Authors:  Ying Zhu; Rui-Xia Zhu; Zhi-Yi He; Xu Liu; He-Nan Liu
Journal:  Neurol Sci       Date:  2015-01-07       Impact factor: 3.307

3.  Neural markers of errors as endophenotypes in neuropsychiatric disorders.

Authors:  Dara S Manoach; Yigal Agam
Journal:  Front Hum Neurosci       Date:  2013-07-18       Impact factor: 3.169

4.  A hypomethylating variant of MTHFR, 677C>T, blunts the neural response to errors in patients with schizophrenia and healthy individuals.

Authors:  Joshua L Roffman; Adam Z Nitenson; Yigal Agam; Marlisa Isom; Jesse S Friedman; Kara A Dyckman; David G Brohawn; Jordan W Smoller; Donald C Goff; Dara S Manoach
Journal:  PLoS One       Date:  2011-09-28       Impact factor: 3.240

5.  Central and systemic responses to methionine-induced hyperhomocysteinemia in mice.

Authors:  Marina Mastelaro de Rezende; Vânia D'Almeida
Journal:  PLoS One       Date:  2014-08-25       Impact factor: 3.240

6.  Chronic exposure of homocysteine in mice contributes to dopamine loss by enhancing oxidative stress in nigrostriatum and produces behavioral phenotypes of Parkinson's disease.

Authors:  Nivedita Bhattacharjee; Rajib Paul; Anirudha Giri; Anupom Borah
Journal:  Biochem Biophys Rep       Date:  2016-02-26

7.  Serum B12, Homocysteine Levels, and their Effect on Peripheral Neuropathy in Parkinson's Disease: Indian Cohort.

Authors:  Neeharika L Mathukumalli; Mridula R Kandadai; Jabeen A Shaik; Meena A Kanikannan; Rupam Borgohain
Journal:  Ann Indian Acad Neurol       Date:  2020 Jan-Feb       Impact factor: 1.383

8.  Homocysteine Level and Mechanisms of Injury in Parkinson's Disease as Related to MTHFR, MTR, and MTHFD1 Genes Polymorphisms and L-Dopa Treatment.

Authors:  Agata Rozycka; Pawel P Jagodzinski; Wojciech Kozubski; Margarita Lianeri; Jolanta Dorszewska
Journal:  Curr Genomics       Date:  2013-12       Impact factor: 2.236

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.